دورية أكاديمية
ENDOCRINOLOGY IN PREGNANCY: Targeting metabolic health promotion to optimise maternal and offspring health.
| العنوان: | ENDOCRINOLOGY IN PREGNANCY: Targeting metabolic health promotion to optimise maternal and offspring health. |
|---|---|
| المؤلفون: | McLennan NM; MRC Centre for Reproductive Health, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, UK., Hazlehurst J; Department of Diabetes and Endocrinology, University Hospital Birmingham Foundation Trust, Birmingham, UK., Thangaratinam S; WHO Collaborating Centre for Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.; Birmingham Women's and Children's NHS Trust, Birmingham, UK., Reynolds RM; BHF/University Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, UK. |
| المصدر: | European journal of endocrinology [Eur J Endocrinol] 2022 Apr 29; Vol. 186 (6), pp. R113-R126. Date of Electronic Publication: 2022 Apr 29. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2023- : Oxford : Oxford University Press Original Publication: Oslo, Norway : Scandinavian University Press, c1994- |
| مواضيع طبية MeSH: | COVID-19* , Diabetes Mellitus, Type 2* , Diabetes, Gestational*/prevention & control , Gestational Weight Gain*, Female ; Health Promotion ; Humans ; Infant ; Pandemics ; Pregnancy |
| مستخلص: | There is an increase in maternal metabolic burden due to the rise in pregnancies complicated by obesity, gestational diabetes, type 2 diabetes and polycystic ovary syndrome. Metabolic dysfunction during pregnancy is associated with increased risks of long-term morbidity and mortality for women and their offspring. Lifestyle interventions in pregnancy in women at risk of metabolic dysfunction have demonstrated short-term improvements such as reduced gestational weight gain and lowered risk of gestational diabetes. It is not known whether these interventions lead to sustained improvements in the metabolic health of the mother and baby. Pharmacological interventions have also shown benefits for the mother and baby in pregnancy, including improvements in glycaemic control, reduction in gestational weight gain and reduction in large for gestational age infants; however, there remains uncertainty over long-term outcomes for mother and child. Existing studies on interventions targeting metabolic health are limited to selected populations in the preconception and postpartum periods and lack follow-up beyond delivery of the intervention. The COVID-19 pandemic has refocused our attention on the effects of maternal metabolic ill-health that play a role in contributing to premature morbidity and mortality. There is an urgent need for strategies to accurately identify the growing number of women and offspring at risk of long-term adverse metabolic health. Strategies which focus on early identification and risk stratification using individualised risk scores in the pre and inter-conception periods must take priority if we are to target and improve the metabolic health of women and their offspring who are at highest risk. |
| References: | N Engl J Med. 2005 Jun 16;352(24):2477-86. (PMID: 15951574) BMJ. 2013 Aug 13;347:f4539. (PMID: 23943697) BMJ Open. 2021 Jun 11;11(6):e048119. (PMID: 34117047) J Clin Med. 2020 Aug 13;9(8):. (PMID: 32823771) Diabetes Res Clin Pract. 2014 Dec;106(3):401-11. (PMID: 25438939) Am J Obstet Gynecol. 2018 Jun;218(6):573-580. (PMID: 29454871) Lancet Diabetes Endocrinol. 2021 Jul;9(7):419-426. (PMID: 33989535) N Engl J Med. 2009 Oct 1;361(14):1339-48. (PMID: 19797280) Cochrane Database Syst Rev. 2017 Nov 05;11:CD012037. (PMID: 29103210) Prev Chronic Dis. 2011 Nov;8(6):A124. (PMID: 22005617) Diabet Med. 2021 Jan;38(1):e14380. (PMID: 32750184) BJOG. 2019 Jul;126(8):973-982. (PMID: 30891907) Diagn Progn Res. 2021 Mar 8;5(1):5. (PMID: 33678196) Lancet Diabetes Endocrinol. 2021 Mar;9(3):153-164. (PMID: 33516295) Prim Care Diabetes. 2019 Apr;13(2):134-141. (PMID: 30448412) J Clin Med. 2019 Dec 02;8(12):. (PMID: 31810312) J Med Internet Res. 2021 Mar 10;23(3):e21435. (PMID: 33688832) BMJ. 2017 Feb 8;356:j1. (PMID: 28179267) Diabetologia. 2021 Apr;64(4):805-813. (PMID: 33486538) Obes Rev. 2020 Apr;21(4):e12990. (PMID: 31914234) Lancet Diabetes Endocrinol. 2020 Oct;8(10):834-844. (PMID: 32946820) Hum Reprod. 2021 Jul 19;36(8):2345-2357. (PMID: 34046665) Int J Gynaecol Obstet. 2020 Sep;151 Suppl 1:16-36. (PMID: 32894590) Diabetologia. 2019 Oct;62(10):1938-1947. (PMID: 31353418) BMJ. 2012 May 16;344:e2088. (PMID: 22596383) Am J Obstet Gynecol. 2010 Nov;203(5):467.e1-6. (PMID: 20630491) BMC Pregnancy Childbirth. 2021 Mar 5;21(1):182. (PMID: 33673827) Lancet. 2018 Feb 10;391(10120):541-551. (PMID: 29221645) Obstet Gynecol. 2018 Dec;132(6):e228-e248. (PMID: 30461693) PLoS One. 2017 Oct 19;12(10):e0185873. (PMID: 29049303) Can Fam Physician. 2013 Jan;59(1):27-31. (PMID: 23341653) Am J Obstet Gynecol. 2020 Aug;223(2):246.e1-246.e10. (PMID: 32017923) Lancet Diabetes Endocrinol. 2020 Sep;8(9):793-800. (PMID: 32822601) Diabetes Care. 2010 Mar;33(3):676-82. (PMID: 20190296) Lancet Diabetes Endocrinol. 2019 Mar;7(3):169-172. (PMID: 30581081) Lancet. 2009 May 23;373(9677):1773-9. (PMID: 19465232) JAMA. 2014 Apr 16;311(15):1536-46. (PMID: 24737366) Hum Reprod. 2017 Sep 1;32(9):1925-1940. (PMID: 28854715) BMC Pregnancy Childbirth. 2018 Dec 12;18(1):488. (PMID: 30541506) BMJ. 2019 Dec 4;367:l6398. (PMID: 31801789) Diabetologia. 2016 Jul;59(7):1403-1411. (PMID: 27073002) BMJ Open. 2019 May 5;9(5):e023014. (PMID: 31061012) PLoS Med. 2019 Jul 23;16(7):e1002857. (PMID: 31335871) Diabetologia. 2019 Aug;62(8):1412-1419. (PMID: 31214738) Diabetologia. 2017 Oct;60(10):1913-1921. (PMID: 28702810) BMJ. 2017 Jul 19;358:j3119. (PMID: 28724518) Obes Rev. 2021 Jan;22(1):e13122. (PMID: 33316148) BJOG. 2005 Oct;112(10):1431-3. (PMID: 16167951) Br J Gen Pract. 2014 Jan;64(618):e17-23. (PMID: 24567578) Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010932. (PMID: 26171908) J Med Internet Res. 2020 Sep 15;22(9):e21573. (PMID: 32930674) Lancet Diabetes Endocrinol. 2020 Jun;8(6):490-500. (PMID: 32445736) J Clin Endocrinol Metab. 2010 Dec;95(12):5365-9. (PMID: 20702520) J Dev Orig Health Dis. 2022 Jun;13(3):390-394. (PMID: 34134812) BMJ. 2020 Sep 1;370:m3320. (PMID: 32873575) Hum Reprod. 2020 Aug 1;35(8):1914-1921. (PMID: 32644124) BMJ. 2020 May 13;369:m1361. (PMID: 32404325) Diabetes Care. 2019 Mar;42(3):372-380. (PMID: 30655380) Obstet Gynecol. 2015 Jan;125(1):144-152. (PMID: 25560116) Can J Diabetes. 2018 Apr;42 Suppl 1:S255-S282. (PMID: 29650105) BJOG. 2019 Feb;126(3):e62-e106. (PMID: 30465332) Prenat Diagn. 2020 Aug;40(9):1085-1091. (PMID: 32946125) Diabetes Care. 2020 Jul;43(7):1617-1635. (PMID: 32561617) Cochrane Database Syst Rev. 2018 Jul 24;7:CD010564. (PMID: 30039871) Diabetologia. 2019 Jun;62(6):905-914. (PMID: 30843102) BMJ Open. 2017 Jun 24;7(6):e015557. (PMID: 28647726) Lancet Diabetes Endocrinol. 2016 Dec;4(12):1037-1049. (PMID: 27743977) Syst Rev. 2019 Nov 11;8(1):270. (PMID: 31711547) Diabetes Care. 2021 Jan;44(Suppl 1):S200-S210. (PMID: 33298425) Fertil Steril. 2017 Aug;108(2):333-340. (PMID: 28778282) Reproduction. 2010 Sep;140(3):387-98. (PMID: 20562299) Diabet Med. 2020 Sep;37(9):1482-1489. (PMID: 32144795) Diabetes Care. 2014 Jun;37(6):1590-6. (PMID: 24705609) BJOG. 2016 Jan;123(2):163-4. (PMID: 26841209) BMC Pregnancy Childbirth. 2020 Apr 6;20(1):198. (PMID: 32252676) Diabetologia. 2019 Apr;62(4):598-610. (PMID: 30648193) Diabetes Care. 2021 Sep;44(9):2182. (PMID: 34135016) Diabetes Care. 2007 May;30(5):1314-9. (PMID: 17290037) PLoS Med. 2019 Aug 6;16(8):e1002848. (PMID: 31386659) Diabetologia. 2021 Mar;64(3):481-490. (PMID: 33404682) |
| تواريخ الأحداث: | Date Created: 20220405 Date Completed: 20220503 Latest Revision: 20240827 |
| رمز التحديث: | 20240827 |
| مُعرف محوري في PubMed: | PMC9066590 |
| DOI: | 10.1530/EJE-21-1046 |
| PMID: | 35380983 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1479-683X |
|---|---|
| DOI: | 10.1530/EJE-21-1046 |